On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
On Apr. 8, 2022, Novavax announced and Serum Institute of India (SII), the world’s largest vaccine manufacturer by…
On Apr. 1, 2022, Merck and Ridgeback Biotherapeutics announced that data evaluating LAGEVRIO(molnupiravir), an investigational oral antiviral COVID-19…
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
On Mar. 25, 2022, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
On Mar. 18, 2022, the World Health Organization (WHO) announced that Malawi had launched the first round of…
On Mar. 2, 2022, Sorrento Therapeutics announced that new preclinical results demonstrated that pretreating an animal with intranasal…
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,…
On Feb. 14, 2022, CDC reported that the current risk to the general publicï¾’s health from HPAI A(H5N1)…
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…
On Jan. 27, 2022, Cocrystal Pharma announced that it had selected two investigational novel antiviral drug candidates for…
On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…
On Jan. 25. 2022, a report published in PNAS provided strong evidence of extensive SARS-CoV-2 infection of white-tailed…
On Jan, 25, 2022, Cepheid announced that Health Canada had issued Cepheid a medical device license for Xpert…
On Jan. 24, 2022, Pfizer and BioNTech announced the publication of new results from two laboratory studies demonstrating…
On Jan. 24, 2022, Anixa Biosciences announced that the company and its partner, MolGenie, had synthesized a compound…
On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…
On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…
On Jan. 19, 2022, Novavaxa announced that Australia’s Therapeutic Goods Administration had granted approval for provisional registration of…
On Jan. 14, 2022, the U.S. Department of Agricultureï¾’s National Veterinary Services Laboratories confirmed a highly pathogenic Eurasian…
On Jan. 13, 2022, OraSure Technologies that its InteliSwabï¾® COVID-19 rapid tests detected the Omicron variant as effectively…
On Jan. 13, 2022, the Centers for Disease Control and Prevention announced a study published in the journal…
On Jan. 5, 2022, Pfizer and BioNTech announced a new research, development and commercialization collaboration to develop a…
On Jan 5, 2022, Hologic the addition of the Aptimaï¾® SARS-CoV-2 assay to its Global Access Initiative, a…
On Jan 5, 2022, Revelar Biotherapeutics and Twist Bioscience announced that RBT-0813 binded to and neutralized the Omicron…
On Dec. 28, 2021, Pacific Biosciences announced that its new HiFiViral SARS-CoV-2 solution had successfully sequenced and captured…
On Dec. 28, 2021, researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland announced…